Mead Johnson Infant Formula NEC Lawsuit
Case Overview
The legal action involved allegations that Mead Johnson's infant formula contributed to a premature baby developing necrotizing enterocolitis (NEC), a severe intestinal disease. The case was heard in an Illinois federal jury trial, where the jury ultimately found that Mead Johnson was not responsible for the fatal condition.
The plaintiffs argued that Mead Johnson failed to adequately warn healthcare providers about the increased risk of NEC associated with using its Enfamil premature formula. Mead Johnson countered by asserting that the child's illness and death were due to the baby's extreme prematurity and other medical issues, not the formula itself, and that the company had not evidence of the formula causing the disease.
The lawsuit was part of a larger multidistrict litigation (MDL) consolidating over 800 claims against Mead Johnson and Abbott Laboratories. The article reports on the jury's verdict but does not provide current settlement terms or a claims deadline for affected individuals.
Who May Qualify
Premature infants whose care involved cow’s-milk-based formula, such as Similac or Enfamil, and who were diagnosed with necrotizing enterocolitis (NEC).
Frequently Asked Questions
What is necrotizing enterocolitis (NEC)?
NEC is a serious condition that causes intestinal tissue to die, which was the fatal disease alleged to be caused by the infant formula.
What was the outcome of the Mead Johnson trial?
A federal jury in Illinois sided with Mead Johnson, rejecting the claims that the company was liable for selling a defective product or failing to warn about the risks of its formula.
What is the scope of the MDL?
The multidistrict litigation consolidates more than 800 lawsuits alleging that infant formulas manufactured or sold by Mead Johnson or Abbott Laboratories caused or contributed to the development of NEC in infants.
Related Cases
Jeep Hybrid SUV Misrepresentation Lawsuit
Graco Baby Swing Defect Class Action